NCT06368206

Brief Summary

The present study, OBPM\_Calfree2024, with N = 85 participants minimum over 1 visit (lasting around 1h), has been designed to collect raw optical data with Aktiia.product-G2C Clinical investigational system together with several reference systems within a cohort of subjects characterized by a wide variety of phenotypes.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
85

participants targeted

Target at P25-P50 for not_applicable hypertension

Timeline
Completed

Started Jun 2024

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 4, 2024

Completed
12 days until next milestone

First Posted

Study publicly available on registry

April 16, 2024

Completed
2 months until next milestone

Study Start

First participant enrolled

June 25, 2024

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2025

Completed
Last Updated

December 17, 2024

Status Verified

December 1, 2024

Enrollment Period

1.5 years

First QC Date

April 4, 2024

Last Update Submit

December 12, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Number of study subjects that contribute with analyzable raw data collected

    Min 85 study subjects contribute with analyzable raw data collected

    1 hour

Secondary Outcomes (3)

  • Blood pressure mean value of differences

    1 hour

  • Blood pressure standard deviation of differences

    1 hour

  • Pulse rate root-mean-square error

    1 hour

Study Arms (1)

Aktiia G2C and references/ comparators for Blood Pressure and Pulse Rate monitoring

OTHER

All study participants will test the investigational device (Aktiia G2C) and other marketed devices for blood pressure and pulse rate measurements (Aktiia Bracelet G2, Double auscultation, oscillometric monitors, finger pulse oximeter).

Device: Investigational device Aktiia G2CDevice: Marketed device used as reference for blood pressure monitoring: double auscultation cuffDevice: Marketed device used as comparative device for blood pressure and pulse rate monitoring: Aktiia Bracelet G2Device: Marketed device used as comparative device for blood pressure and pulse rate monitoring: oscillometric upper-arm cuffDevice: Marketed device used as comparative device for blood pressure and pulse rate monitoring: oscillometric wrist cuffDevice: Marketed device used as reference for pulse rate monitoring: pulse finger oximeter

Interventions

Study subjects are asked to stay seated and relaxed while successive measurements are taken with Aktiia G2C.

Aktiia G2C and references/ comparators for Blood Pressure and Pulse Rate monitoring

Study subjects are asked to stay seated and relaxed while successive measurements are taken with cuff for double auscultation.

Aktiia G2C and references/ comparators for Blood Pressure and Pulse Rate monitoring

Study subjects are asked to stay seated and relaxed while successive measurements are taken with Aktiia Bracelet G2.

Aktiia G2C and references/ comparators for Blood Pressure and Pulse Rate monitoring

Study subjects are asked to stay seated and relaxed while taking successive measurements with an oscillometric upper-arm cuff.

Aktiia G2C and references/ comparators for Blood Pressure and Pulse Rate monitoring

Study subjects are asked to stay seated and relaxed while taking successive measurements with an oscillometric wrist cuff.

Aktiia G2C and references/ comparators for Blood Pressure and Pulse Rate monitoring

Study subjects are asked to stay seated and relaxed while successive measurements are taken with pulse finger oximeter.

Aktiia G2C and references/ comparators for Blood Pressure and Pulse Rate monitoring

Eligibility Criteria

Age21 Years - 85 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Subjects aged 21 to 85yo
  • Subjects fluent in written and spoken French
  • Subjects agreeing to attend the study visit and follow study procedures
  • Subjects that have signed the informed consent form.

You may not qualify if:

  • Amputated index fingers
  • Damaged/injured skin at index fingers
  • Damaged/injured skin at wrists
  • Subjects suffering from sustained cardiac arrhythmias that can lead to weak or unstable pressure pulses including tachycardia (heart rate at rest \> 120bpm) and atrial fibrillation
  • Subjects suffering from pathologies that systematically reduce peripheral perfusion including Raynaud's disease, diabetes, renal dysfunctions (eGFR \< 30mL/min/1.73 m2), hyper-/hypothyroidism, pheochromocytoma or arteriovenous fistula
  • Pregnant women
  • Polyneuropathy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CHUV

Lausanne, 1011, Switzerland

RECRUITING

MeSH Terms

Conditions

Hypertension

Interventions

Blood Pressure

Condition Hierarchy (Ancestors)

Vascular DiseasesCardiovascular Diseases

Intervention Hierarchy (Ancestors)

Vital SignsPhysical ExaminationDiagnostic Techniques and ProceduresDiagnosisHemodynamicsCardiovascular Physiological PhenomenaCirculatory and Respiratory Physiological Phenomena

Central Study Contacts

Grégoire Wuerzner, Medical Doctor Prof.

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Model Details: 1 study cohort that will test investigational device (Aktiia G2C) and Blood Pressure and Pulse Rate references.
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 4, 2024

First Posted

April 16, 2024

Study Start

June 25, 2024

Primary Completion

December 31, 2025

Study Completion

December 31, 2025

Last Updated

December 17, 2024

Record last verified: 2024-12

Data Sharing

IPD Sharing
Will not share

Locations